HALOZYME THERAPEUTICS $7.45

up +0.28


23/5/2013 04:23 PM  |  NASDAQ : HALO  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
12 Mo. Price Change : -11% - HALO has underperformed the S&P 500 by 36%

Get Trend Analysis Icon Get Trend Analysis

Partner Headlines

  1. UPDATE: BMO Capital Markets Reiterates Outperform Rating, Lowers ...

    Benzinga

  2. Jefferies Reiterates Underperform Rating, $4 PT on Halozyme ...

    Benzinga

  3. Mid-Afternoon Market Update: Herbalife Rises Above Ackman's Top, ...

    Benzinga

  4. UPDATE: BMO Capital Markets Upgrades Halozyme Therapeutics to ...

    Benzinga

  5. The Story Behind Little Halozyme's Seemingly Exciting Hookup With ...

    YCharts

  6. Halozyme Soars After Announcing Deal With Pfizer

    Benzinga

  7. Benzinga's Top Pre-Market Gainers

    Benzinga

  8. Halozyme Therapeutics, Pfizer Collaborate to Develop And ...

    Benzinga

  9. Halozyme Announces Roche Filing to European Medicines Agency ...

    Benzinga

  10. Halozyme Therapeutics Inc. Reports Operating Results (10-Q)

    GuruFocus

  11. Analyst Upgrades: Halozyme Therapeutics, Zillow, and Celgene

    By SchaeffersResearch

  12. Benzinga's M&A Chatter for Wednesday September 26, 2012

    Benzinga

  13. ViroPharma up, FDA lifts ban

    Investors Business Daily

  14. Benzinga Mid-Afternoon Market Update

    Benzinga

  15. Benzinga Mid-Day Market Update

    Benzinga

  16. ViroPharma, Halozyme Rise After FDA Issue Cleared Up

    Investors Business Daily

  17. Halozyme Therapeutics Inc. (HALO) CEO Gregory Ian Frost buys 2,000 ...

    GuruFocus

  18. Halozyme Therapeutics Inc. Reports Operating Results (10-Q)

    GuruFocus

  19. UPDATE: Jefferies Downgrades Halozyme Therapeutics to Underperform ...

    Benzinga

  20. Health Care Sector Wrap

    FOXBusiness

  21. Halozyme's Ultrafast Insulin Formulations Improved Postprandial ...

    Benzinga

  22. Wedbush Reiterates Outperform Rating for Halozyme Therapeutics

    Benzinga

  23. Stocks Narrowly Mixed as Earnings and Data Roll in with Mattel ...

    At Market Intelligence Center

  24. Baxter

    at IBD

  25. Baxter International (BAX) Loses 5.4% on FDA Request for ...

    At Market Intelligence Center

  26. Halozyme Therapeutics (HALO) Loses 20.9% After FDA Asks For More ...

    At Market Intelligence Center

  27. Baxter, Halozyme Stocks Plunge On FDA Delay

    at IBD

  28. Halozyme Q4 results fall short

    at IBD

  29. Earnings Scheduled For March 9

    at Benzinga

  30. ViroPharma and Halozyme Announce Positive Data of Subcutaneous ...

    at Benzinga

  31. Bullish Bettors Take a Shine to Halozyme Therapeutics Calls

    By SchaeffersResearch

  32. Halozyme Therapeutics

    at IBD

  33. Halozyme (HALO) Loses 1% After Pricing 6.8 Million Share ...

    At Market Intelligence Center

  34. Halozyme Announces Proposed Public Offering of Common Stock; 6.8M ...

    at Benzinga
People viewing HALO also viewed: , , , , , ,
Marketplace
Trading Center